Integer Holdings stock slips after weak third-quarter results

Published on 11/03/2026 at 00:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Integer Holdings stock faces a weaker earnings picture after third-quarter sales and adjusted profit declined. The pending KKR transaction remains the next major catalyst.

Integer faces weaker quarterly results

Third-quarter sales and adjusted earnings declined year over year.
Cardiac rhythm management and neuromodulation growth partly offset weaker cardio and vascular sales.
The planned KKR transaction is expected to close by the end of 2026, subject to remaining conditions.

ITGR, US45826H1095, Illustration mit AI erstellt.

Integer Holdings reported weaker third-quarter results on October 29, with sales and adjusted earnings declining from a year earlier. The medical device manufacturer also said it would not provide financial outlook or hold an earnings call because of its pending transaction with an affiliate of KKR. The company release covered the three months ended October 2, 2026.

Sales and adjusted profit decline

Sales fell 3.9 percent to 449.661 million US dollars, while organic sales declined 2.2 percent. GAAP operating income dropped 50 percent to 28.209 million US dollars, and adjusted operating income decreased 22.8 percent to 66.290 million US dollars.

Adjusted net income fell 26.9 percent to 46.140 million US dollars. Adjusted diluted earnings per share declined 25.1 percent to 1.34 US dollars from 1.79 US dollars in the prior-year quarter. The company said the adjusted measures are non-GAAP figures.

Product lines send mixed signals

Cardio and vascular sales decreased 5.1 percent to 263.076 million US dollars. Cardiac rhythm management and neuromodulation sales rose 3.9 percent to 175.835 million US dollars, partly offsetting the decline. Other Markets sales fell to 10.750 million US dollars from 21.386 million US dollars, primarily because of the Portable Medical exit.

Integer Holdings stock traded at 112.50 euros on Lang & Schwarz at 11:00 p.m. CET on Monday, November 2, 2026. The real-time quote of Integer Holdings stock provides the latest trading view.

KKR deal sets the next milestone

Integer said stockholders approved the merger agreement on October 21. The transaction is expected to close by the end of 2026, subject to remaining customary closing conditions and required regulatory approvals. The company reported total debt of 1.219 billion US dollars and a leverage ratio of 3.3 times adjusted EBITDA as of October 2.

Medical device CDMO profile

Integer Holdings is a medical device contract development and manufacturing organization serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. Its brands include Greatbatch Medical and Lake Region Medical. The company is based in Plano, Texas, and describes itself as one of the world's largest medical device CDMOs, with engineering and manufacturing services for medical device customers.